Dr. Liachko and Heather Currey Share Their Experience in using the ScreenChip System
31 May 2017
As a researcher at the University of Washington, Dr. Liachko is focused on improving the health of American Veterans and patients affected by neurodegenerative disease. Her goal is to understand the molecular mechanisms driving neurodegenerative diseases of aging such as amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD-TDP), and to help develop improved therapeutic interventions for these devastating diseases.
About the company
InVivo Biosystems
InVivo Biosystems mission is to accelerate deep in-vivo insights into human biology and enable researchers to develop and deliver solutions that improve human health.
InVivo Biosystems creates custom genome-edited C. elegans and zebrafish models to enable aging, developmental and disease studies. Our unique living platforms and technologies bridge the gap between cells and mice, providing faster, cost-effective investigations that focus on proof-of-principle experiments for rapid go/no-go decision making and advance the discovery and early-stage development of new compounds.
InVivo Biosystems provides essential services to help pharmaceutical, nutraceutical, biotechnology companies and academic research institutions around the globe accelerate their research and drug development efforts.
